Prof. Xiao Zhang | biomaterials | Best Researcher Award

Prof. Xiao Zhang | biomaterials | Best Researcher Award

Prof. Xiao Zhang, Shanxi Medical University, China

Dr. Xiao Zhang is a Professor in the Department of Pharmacy at Shanxi Medical University, specializing in drug/gene delivery and biomaterials. With a Ph.D. in Pharmaceutics from Sichuan University, his research focuses on designing smart nanoplatforms for tumor therapy and bone regeneration. Dr. Zhang has extensive experience in developing therapeutic biomaterials and multifunctional scaffolds. His innovative work has earned him numerous publications and patents. He has presented his work at major academic conferences, furthering the field of pharmaceutical nanotechnology. šŸ§¬šŸ’ŠšŸ¦ 

Professional Profile:

Scopus

Summary of Suitability for Best Researcher Award

Dr. Xiao Zhang is exceptionally qualified for the Best Researcher Award due to his groundbreaking work in the fields of drug and gene delivery, biomaterials, and pharmaceutical nanotechnology. His career is marked by a unique combination of academic excellence, innovative research, and tangible contributions to the advancement of drug delivery systems and therapeutic biomaterials.

Education & Experience

  • Ph.D. in Pharmaceutics, Sichuan University, 09/2013-06/2018 šŸŽ“
  • B.E. in Pharmaceutical Engineering, University of Jinan, 09/2009-07/2013 šŸŽ“
  • Professor, Shanxi Medical University, 07/2020-present šŸ«
  • Postdoctoral Researcher, University of California, Los Angeles, 10/2018-10/2019 šŸŒ
  • Research Focus: Nanotechnology in drug/gene delivery and biomaterials šŸ§¬

Professional Development

Dr. Zhang has significantly contributed to the field of pharmaceutics with a focus on nanoplatforms for drug delivery and tumor therapy. His postdoctoral research at UCLA expanded his expertise in biomaterials, and he has since led multiple successful research projects as a principal investigator. Through academic conferences and collaborations, he has continually refined his knowledge of peptide-based dendrimers and smart nanomaterials for medical applications. His work stands at the intersection of pharmacy, materials science, and biotechnology, pushing the boundaries of therapeutic innovation. šŸ”¬šŸ’”šŸ“ˆ

Research Focus

Dr. Zhangā€™s research focuses on the design and development of smart nanoplatforms for drug and gene delivery, aiming to enhance tumor therapy and bone regeneration. His work involves creating bioinspired peptide-based dendrimers, nanoparticles, and multifunctional scaffolds for osteogenesis and cancer treatment. He is dedicated to overcoming the challenges of drug-resistant tumors by engineering novel nanomaterials that improve therapeutic efficiency and bioavailability. His goal is to revolutionize how medicines are delivered within the body, using cutting-edge nanotechnology and biomaterials. šŸ’‰šŸ’ŽšŸ¦µ

Awards & Honors

  • Patent: Nanoparticles for tumor-activated dual-penetration (Patent No. 201710853408.7) šŸ…
  • Patent: Chiral dendritic peptide for autophagy induction (Patent No. 201710611754.4) šŸ…
  • Patent: Tumor-specific dendrimeric prodrugs (Patent No. 201610999722.1) šŸ…
  • Oral Presentation: “Tryptophan-Rich Peptide Dendrimers Mimicking Protein Drugs” at the 2015 China Materials Conference šŸ†
  • Oral Presentation: 2015 China Biomaterials Conference šŸ†

Publication Top Notes:

  • Title: Complementary modulation of BMP signaling improves bone healing efficiency
    • Citations: 3
  • Ā Title: Natural Chlorogenic Acid Planted Nanohybrids with Steerable Hyperthermia for Osteosarcoma Suppression and Bone Regeneration
    • Citations: 6
  • Ā Title: Molecular and supramolecular engineering on lipopeptide-based hole-punching nanotoxins to trigger multimodal death of drug-resistant tumors: Apoptosis, necrosis and autophagy
    • Citations: 5
  • Ā Title: Investigation of the internalization and transport mechanism of Codonopsis Radix polysaccharide both in mice and Caco-2 cells
    • Citations: 15
  • Ā Title: Pharmacokinetics, distribution and excretion of inulin-type fructan CPA after oral or intravenous administration to mice
    • Citations: 7

 

 

Dr. Richard Bright | Biomaterials Awards | Best Researcher Award

Dr. Richard Bright | Biomaterials Awards | Best Researcher Award

Dr. Richard Bright , Flinders University, College of Medicine , Australia

Richard John Bright is currently a Research Fellow in Nanomedicine at the Biomedical Nanoengineering Laboratory, College of Medicine and Public Health, Flinders University, a position he has held since June 2022. Prior to this role, he was a Research Associate in STEM at the School of Engineering, University of South Australia, from March 2018 to June 2022. He also served as a Senior Research Officer and Laboratory Manager for both the Translational Research in Oral Health Science at the School of Dentistry, The University of Adelaide (June 2012 – November 2018), and the Immunotherapy Research Laboratory at the Royal Adelaide Hospital (June 2014 – November 2018). Richard holds a PhD in Medicine from Flinders University (2024), focusing on “Enhancing Osseointegration and Preventing Implant-Associated Infections Through Biomimetic Nano-Modifications.” He earned his Master of Applied Science from Charles Sturt University in 2013, specializing in “Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy,” and a Postgraduate Diploma in Biological Science from Charles Sturt University in 2010. Richard also completed his Bachelor of Science with Honours in Molecular Biology and Genetics at The University of Adelaide in 2007.

Professional Profile:

Orcid

Suitability for the Best Researcher Award: Richard Bright

Richard Bright is a distinguished candidate for the Best Researcher Award due to his extensive expertise and substantial contributions in the field of nanomedicine and biomedical engineering. His research, primarily focused on the development and application of biomimetic nanostructured surfaces for medical and dental applications, demonstrates a high level of innovation and impact.

šŸŽ“Education:

Richard John Bright holds a PhD in Medicine from Flinders University (2024), where his research focused on “Enhancing Osseointegration and Preventing Implant-Associated Infections Through Biomimetic Nano-Modifications.” He earned his Master of Applied Science in 2013 from Charles Sturt University, specializing in “Therapeutic Options for Chronic Inflammatory Demyelinating Polyradiculoneuropathy.” Prior to that, he completed a Postgraduate Diploma in Biological Science at Charles Sturt University in 2010. Richard also holds a Bachelor of Science with Honours from The University of Adelaide (2007), where he majored in Molecular Biology and Genetics.

šŸ¢Experience:

Richard John Bright is currently a Research Fellow in Nanomedicine at the Biomedical Nanoengineering Laboratory, College of Medicine and Public Health, Flinders University, a position he has held since June 2022. Prior to this, he served as a Research Associate in STEM at the School of Engineering, University of South Australia, from March 2018 to June 2022. His earlier roles include Senior Research Officer and Laboratory Manager for the Translational Research in Oral Health Science at the School of Dentistry, The University of Adelaide (June 2012 – November 2018), and Senior Research Officer and Laboratory Manager for the Immunotherapy Research Laboratory at the Royal Adelaide Hospital (June 2014 – November 2018).

Publication Top Notes:

  • Development of ā€œIntelligent particlesā€ for the treatment of dental caries
  • Facile green synthesis of dual stabilized near-infrared CuInSe/ZnS quantum dots as fluorescent probes for cancer-bacteria imaging
  • Exploring the Challenges of Characterising Surface Topography of Polymerā€“Nanoparticle Composites
  • Development of Microneedles for Antimicrobial Drug Delivery: A Comprehensive Review on Applications in Wound Infection Management
  • Advancing sustainable technologies

 

 

 

 

Dr. Elton da Cruz Pereira | Biomaterials Award | Best Researcher Award

Dr. Elton da Cruz Pereira | Biomaterials Award | Best Researcher Award

Dr. Elton da Cruz Pereira , State University of MaringĆ” and Paranaense University , Brazil

Elton da Cruz Alves Pereira is a multifaceted professional with a diverse educational background and extensive expertise across several disciplines. He holds a Biomedical degree from the State University of MaringĆ” (UEM) and a Civil Engineering degree from the University of Uberaba (UNIUBE). He furthered his education with a postgraduate degree in Biomedical Engineering focusing on Clinical Engineering from ESTƁCIO and obtained a Master’s in Health Sciences from PCS/UEM. Currently pursuing a PhD in Health Sciences at PCS/UEM and another in Biotechnology Applied to Agriculture at Paranaense University (UNIPAR), Elton is also interning in the Medicine course at UNIPAR. His professional journey includes technical training as a Nursing Technician and Assistant at APROVE/SENAI, with experience as a first aider in the Mobile Emergency Care Service (SAMU) in MaringĆ”/PR. Elton’s expertise spans Medical, Nursing, Biomedical, and Biomedical Engineering fields, focusing on Intensive Care Units (ICU), Pre-hospital Care, Clinical Analysis, and research in Mycology and 3D Artificial Tissue Engineering. He is actively involved in several research initiatives, including the CNPq Technologies Research group and the HOPE Curative Project under the CENTELHA II – PR program. Elton is also the Founder and CEO of Startup CellEng Biomedical and participates in MaringĆ”/PR’s Hub Connect Health initiative.

Professional Profile:

Orcid

Education:

Elton da Cruz Alves Pereira has built a robust educational background spanning diverse disciplines. He holds a Biomedical degree from the State University of MaringĆ” (UEM) and a Civil Engineering degree from the University of Uberaba (UNIUBE). His academic journey continued with a postgraduate degree in Biomedical Engineering, focusing on Clinical Engineering, from ESTƁCIO, followed by a Master’s in Health Sciences from PCS/UEM. Currently, Elton is concurrently pursuing two doctoral degrees: one in Health Sciences at PCS/UEM and another in Biotechnology Applied to Agriculture at Paranaense University (UNIPAR). His academic pursuits reflect his commitment to advancing knowledge and expertise across multiple domains within the biomedical and health sciences fields.

Work Experience:

Elton da Cruz Alves Pereira has amassed a diverse professional background through various roles. He began as a Nursing Technician and Assistant at APROVE/SENAI, where he gained practical experience in healthcare. Subsequently, he served as a First Aider in the Mobile Emergency Care Service (SAMU) in the Municipality of MaringĆ”/PR, demonstrating his commitment to emergency medical response and patient care. Alongside his clinical roles, Elton is the Founder and CEO of Startup CellEng Biomedical, highlighting his entrepreneurial spirit and leadership in biomedical innovation. These positions underscore his breadth of experience across healthcare, emergency services, and biomedical entrepreneurship, shaping his multifaceted career in the field.

Professional Profile:

  • Formulation and Characterization of Nanoemulsion Incorporating Chamomilla recutita L. Extract Stabilized with Hyaluronic Acid
    • Journal: Pharmaceutics
    • Publication Date: 2024-05-23
  • Self-Curing Glass Ionomer Cement Covered by Photopolymerizable Adhesive for Protection of Mucoperiosteal or Gingival Flap Sutures in Canine Oral Surgery
    • Journal: Animals
    • Publication Date: 2023-08-17
  • Hospital Trichosporon asahii isolates with simple architecture biofilms and high resistance to antifungals routinely used in clinical practice
    • Journal: Journal of Medical Mycology
    • Publication Date: 2023-05
  • Polycaprolactone Nanofibers Colonized by HeLa Cells: An Alternative for in vitro Investigation Of Fungal Infection
    • Journal: Future Microbiology
    • Publication Date: 2023-03
  • Geospatial Analysis of Diagnostic Imaging Equipment in Brazil
    • Book Chapter: XXVII Brazilian Congress on Biomedical Engineering
    • Publication Year: 2022